Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Branche, Angela
NCT05736835: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults	Completed	2	227	US	CVXGA, PIV5-SARS CoV-2	CyanVac LLC	COVID-19	07/24	10/24
NCT05870839: Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States	Completed	1	121	US	VXCO-100	Vaccine Company, Inc.	SARS-CoV, SARS-CoV-2	04/24	04/24